The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 years later, she’s pursuing new research on the boundaries of life.

Oneok (NYSE:OKE) +3.9% in Monday's trading as Wolfe Research upgrades shares to Outperform from Peer Perform with a $110 price target, saying the stock has fallen out of favor on near-term Bakken ...

Wolfe Research analyst Myles Walton downgraded Triumph Group (TGI) to Peer Perform from Outperform without a price target after the company ...

CNBC’s Seema Mody and Chris Senyek, Wolfe Research chief investment strategist, join 'Power Lunch' to discuss the Honeywell ...

Wolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating and $25 price target The stock’s current ...

Wolfe Research analyst Shweta Khajuria says Roblox (RBLX) reported a “modest” bookings miss in Q4 versus Street estimates elevated investor expectations with EBITDA posting a slight beat.

Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of AnaptysBio (LSE:0HFQ) with a Outperform recommendation. What is the Fund Sentiment? There are 357 funds or ...

Wolfe Research assumed coverage on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage issued an ...

Fintel reports that on February 3, 2025, Wolfe Research upgraded their outlook for Northrop Grumman (WBAG:NOCO) from Underperform to Peer Perform. There are 2,442 funds or institutions reporting ...